Katherine E Bujold

Title: Katherine E Bujold: Innovator in Oligonucleotide Synthesis

Introduction

Katherine E Bujold is a prominent inventor based in Magog, Canada. She has made significant contributions to the field of oligonucleotide synthesis, holding two patents that showcase her innovative work. Her research focuses on the development of modified oligonucleotides for therapeutic applications.

Latest Patents

Katherine's latest patents include "Deoxynucleic guanidines (DNG)-modified oligonucleotides and methods of synthesizing deoxynucleic guanidine strands." This patent discloses spherical nucleic acids (SNAs) comprising oligonucleotides that include one or more modified oligonucleotides, along with methods for their use. Additionally, she holds a patent for "Stabilized colloidal crystals and methods of stabilizing colloidal crystals," which outlines methods for stabilizing DNA-engineered crystals through cross-linking hybridized oligonucleotides, resulting in improved chemical and thermal stability.

Career Highlights

Katherine is affiliated with Northwestern University, where she continues her research and development in the field of oligonucleotide synthesis. Her work has garnered attention for its potential applications in therapeutics, particularly in the area of gene therapy.

Collaborations

Katherine has collaborated with notable researchers, including Chad A Mirkin and Seungkyu Lee. These collaborations have further advanced her research and contributed to the scientific community's understanding of oligonucleotide applications.

Conclusion

Katherine E Bujold is a trailblazer in the field of oligonucleotide synthesis, with her innovative patents paving the way for future advancements in therapeutics. Her contributions to science and research continue to inspire and influence the field.